Vivani Medical, Inc.

VANI

US92854B1098

Medical Equipment, Supplies & Distribution

End-of-day quote Nasdaq Other stock markets 23:00:00 14/05/2024 BST			5-day change	1st Jan Change
1.91 ^USD	+4.37%		+5.52%	+87.25%

05-13	Vivani Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-26	Vivani Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	CI

Vivani Medical, Inc. Approves Reincorporation Will Change the State of Its Incorporation from California to Delaware

June 16, 2023 at 11:12 am

Vivani Medical, Inc. at the AGM held on June 15, 2023, approved reincorporation to which the Company will change the state of its incorporation from California to Delaware.

Latest news about Vivani Medical, Inc.

Vivani Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-13	CI
Vivani Medical, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	03-26	CI
Vivani Medical, Inc. Appoints Daniel Bradbury to Its Board of Directors	03-06	CI
Vivani Medical Prices $15 Million Registered Direct Offering; Shares Slump	03-01	MT
Sector Update: Health Care Stocks Decline Late Afternoon	02-28	MT
Sector Update: Health Care	02-28	MT
Top Midday Gainers	02-28	MT
Vivani Medical Shares Soar on Positive NPM-115 Preclinical Weight Loss Data	02-28	MT
Vivani shares skyrocket as implant reduces weight in mice	02-28	RE
Vivani Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Vivani Medical Insider Bought Shares Worth $103,368, According to a Recent SEC Filing	25/10/23	MT
Vivani Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23	CI
Vivani Medical, Inc. Approves Reincorporation Will Change the State of Its Incorporation from California to Delaware	16/06/23	CI
Vivani Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	15/05/23	CI
Vivani Medical Receives Final $1 Million National Institutes of Health Grant Funding for Orion Clinical Study	04/04/23	MT
Vivani Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	31/03/23	CI
Pixium Vision Wins Favorable Court Ruling in Failed Merger With Vivani Medical	28/12/22	MT
Vivani Medical, Inc. Enters into A 124-Month Lease Agreement, with 1350 South Loop, LLC	28/11/22	CI
Earnings Flash (VANI) VIVANI MEDICAL Reports Q3 EPS $0.04	14/11/22	MT
Vivani Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	14/11/22	CI
Vivani Medical, Inc.(NasdaqCM:VANI) dropped from S&P Global BMI Index	19/09/22	CI
Vivani Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	02/09/22	CI
Vivani Medical, Inc. Appoints Brigid A. Makes as Chief Financial Officer	02/09/22	CI
Vivani Medical, Inc. Announces Chief Executive Officer Changes	02/09/22	CI
Vivani Medical, Inc. Announces Management Changes	02/09/22	CI

Vivani Medical, Inc. is a preclinical-stage biopharmaceutical company. The Company develops miniaturized and subdermal implants utilizing its NanoPortal technology to enable the delivery of a range of medicines to treat chronic diseases. It is engaged in the development of the Companyâs lead programs NPM-115 and NPM-119, is a GLP-1 implant candidates for the treatment of chronic weight management and patients with type 2 diabetes, respectively. Its other pipeline product candidates include NPM-139, and OKV-119. It uses this platform technology to develop and commercialize drug implant candidates for the treatment of chronic disease and medication non-adherence. It operates through two segments: Biopharm Division and Neuromodulation Division. The Companyâs implant technology, which it refers as NanoPortal, utilizes a space-efficient design that allows a miniaturized implant to provide many months of therapeutic delivery of potent molecules.

Sector

Medical Equipment, Supplies & Distribution

Calendar

02/06/2024 - Bio International Convention

More about the company

Income Statement Evolution

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

1.995 USD

Average target price

8 USD

Spread / Average Target

+301.00%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Devices & Implants

	1st Jan change	Capi.
VIVANI MEDICAL, INC.	+87.25%	110M
SMITH & NEPHEW PLC	-5.10%	11.34B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+4.02%	9.11B
GLAUKOS CORPORATION	+38.12%	5.53B
INSPIRE MEDICAL SYSTEMS, INC.	-23.70%	4.61B
AXONICS, INC.	+8.55%	3.45B
ENOVIS CORPORATION	-6.44%	2.87B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	-5.85%	2.1B
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD.	-11.84%	2.08B
DOUBLE MEDICAL TECHNOLOGY INC.	-23.36%	1.78B

Medical Devices & Implants